To the Editor We read with interest the systematic review of the risk of intraocular bleeding with novel oral anticoagulants compared with warfarin. Sun and colleagues1 identified a modest relative risk reduction in intraocular bleeding with novel anticoagulants compared with warfarin in a meta-analysis of 12 randomized clinical trials with more than 100 000 patients.